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Abstract: A 59-year-old man was mistakenly prescribed Slow-Na instead of Slow-K due to 
incorrect selection from a drop-down list in the prescribing software. This error was identified 
by a pharmacist during a home medicine review (HMR) before the patient began taking the 
supplement. The reported error emphasizes the need for vigilance due to the emergence of 
novel look-alike, sound-alike (LASA) drug pairings. This case highlights the important role of 
pharmacists in medication safety.
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Case report
Medication errors refer to a failure at some point during a treatment process, which may 
lead to patient harm.1 Several studies in current literature identify key issues regard-
ing medication errors, specifically, that they are more likely to occur at interfaces of 
care where there is an element of data transcription.2 The World Health Organization 
has explicitly identified confusing drug names as one of the most common causes of 
medication error.3 Factors that contribute to potential confusion between drug names 
include spelling-related, phonetic, or packaging similarities.4–8 It has been established 
that confusion, and therefore error, is more likely if medicines appear in the same 
context or if drugs are being selected from a drop-down list.4 Multiple studies have 
concluded that look-alike, sound-alike (LASA) errors stem from both human error 
and the failure of prescribing systems across the health care spectrum to be able to 
recognize the potential for these errors.4,5,8 One method consistently recommended to 
decrease LASA errors is Tall Man lettering – a textual format recognized and recom-
mended by the US Federal Drug Administration (FDA), which involves writing the 
“confusable” parts of LASA drug names in uppercase.9 It has been established that 
Tall Man lettering does improve accuracy in the perception of drug names.9
The home medicine review (HMR) program was established in Australia in 2001 
in order to facilitate quality use of medicines through pharmacist intervention. HMRs 
are initiated by a patient’s general practitioner and have been established to be an 
effective tool in medicine safety in a number of patient groups, including those with 
multiple medications, medication barriers (eg, language barriers or visual impair-
ment), or patients undergoing medication changes – such as a recent discharge from 
hospital.10–12
A HMR conducted by an accredited community pharmacist in Australia in 2011 
revealed that a patient was mistakenly prescribed Slow-Na instead of Slow-K. The 
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patient had a medical history of deep vein thrombosis, right 
hip fracture, pulmonary embolism, chronic obstructive 
airway disease, and ischemic heart disease. At the time of 
the HMR, the patient had current prescriptions for warfarin 
sodium (5 mg), frusemide (20 mg), fluticasone propionate/
salmeterol, tiotropium, and salbutamol sulfate, in addition 
to the prescription for Slow-Na (600 mg). It was established 
that the patient was prescribed Slow-K after being diagnosed 
with hypokalemia following an 8-week hospitalization for 
pneumonia. During the prescribing process, Slow-Na was 
mistakenly selected from a drop-down software list (Figure 
1). Due to financial reasons, the patient had not filled the 
incorrect prescription, and the error was identified before 
the patient obtained Slow-Na. Adverse events that may have 
eventuated due to untreated hypokalemia include increased 
risk of arrhythmias, skeletal myopathy, metabolic acidosis, 
and acute kidney injury.13 Increased sodium intake may have 
also resulted in altered mental status.13
Given that this particular LASA error has not been 
reported in the literature to date, it presents a novel drug 
pair listing in LASA errors. Although this particular LASA 
error is unlikely to recur in Australia due to the discontinu-
ation of Slow-Na in 2011, it highlights the ongoing need for 
vigilance with respect to LASA errors, as new drug pairs 
continue to be identified as potential and actual sources 
of error. A recent Australian study commissioned by the 
Australian National Medicines Policy Committee reviewed 
32 publications on LASA medication errors and strategies 
that may be implemented to decrease their incidence.6 The 
review determined that in order to decrease errors from 
LASA medications, all stages of the medication process, from 
manufacture through to administration, must be perused and 
strategies must be designed to address potential problems.6 
This finding is consistent in current literature.1,6 A National 
Tall Man Lettering Standard in prescribing software was the 
recommendation provided by the Australian Commission on 
Safety and Quality in Healthcare following a review.14 The 
recommended standard would only incorporate a set list of 
medications associated with orthographic error.14
In the case reported herein, Tall Man lettering may have 
drawn attention to the LASA error before it perpetuated 
through the medication process to the patient. Given that 
LASA errors are well described in the literature, Australia 
should aspire to develop and apply innovative solutions to 
decrease the incidence of LASA errors to facilitate quality use 
of medicines. This may include widespread use of Tall Man 
Lettering in prescribing and dispensing software. Although 
the error described in the case herein was identified before 
the patient commenced treatment with the incorrect drug, 
it highlights the ongoing need for vigilance with respect 
to LASA errors, as new drug pairs continue to be identi-
fied as potential and actual sources of error. The Slow-Na, 
Slow-K LASA error reported here was identified during a 
HMR. The recognition of the error is a significant example 
of the importance of medication review throughout the 
entire medication process. Pharmacists in particular have 
an important role in the community in implementing and 
undertaking strategies, such as HMRs, to minimize adverse 
drug events to ensure quality use of medicines. This case 
highlights the fundamental role of HMRs in the community 
and these should continue to be utilized as an effective tool 
in identifying LASA errors.
Disclosure
The authors report no conflicts of interest in this work.
References
1. Aronson JK. Medication errors: what they are, how they happen, and 
how to avoid them. QJM. 2009;102(8):513–521.
2. Abdel-Qader DH, Harper L, Cantrill JA, Tully MP. Pharmacists’ inter-
ventions in prescribing errors at hospital discharge: an observational 
study in the context of an electronic prescribing system in a UK teaching 
hospital. Drug Saf. 2010;33(11):1027–1044.
3. WHO. WHO Collaborating Centre for Patient Safety Solutions, Look-
Alike Sound-Alike Medication Names. Patient Safety Solutions. Geneva: 
WHO; 2007.
4. Emmerton L, Rizk MS. Look-alike and sound-alike medicines: risks and 
‘solutions’. Int J Clin Pharm. 2012;34(1):4–8.
5. Hoffman J, Proulx S. Medication errors caused by confusion of drug 
names. Drug Safety. 2003;26(7):445–452.
6. Ostini R, Roughead EE, Kirkpatrick CMJ, Monteith GR, Tett SE.  Quality 
Use of Medicines – medication safety issues in naming; look-alike, 
sound-alike medicine names. Int J Pharm Pract. 2012;20(6):349–357.
7. Aronson JK. Medication errors resulting from the confusion of drug 
names. Expert Opin Drug Saf. 2004;3(3):167–172.
Figure 1 Image of the prescribing software demonstrating the proximity of the 
Lasa drugs.
 
In
te
rn
at
io
na
l M
ed
ica
l C
as
e 
Re
po
rts
 J
ou
rn
al
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
60
.2
41
.3
8.
16
2 
on
 0
7-
Ap
r-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Medical Case Reports Journal
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-medical-case-reports-journal-journal
The International Medical Case Reports Journal is an international, 
peer-reviewed open-access journal publishing original case reports 
from all medical specialties. Previously unpublished medical post-
ers are also accepted relating to any area of clinical or preclinical 
science. Submissions should not normally exceed 2,000 words or 
4 published pages including figures, diagrams and references. The 
manuscript management system is completely online and includes a 
very quick and fair peer-review system, which is all easy to use. Visit 
http://www.dovepress.com/testimonials.php to read real quotes from 
published authors.
International Medical Case Reports Journal 2015:8 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
53
slow-Na, slow-K prescribing error
 8. Kondrak G, Dorr B. Automatic identification of confusable drug 
names. Artif Intell Med. 2006;36(1):29–42.
 9. Darker IT, Gerret D, Filik R, Purdy KJ, Gale AG. The influence of ‘Tall 
Man’ lettering on errors of visual perception in the recognition of written 
drug names. Ergonomics. 2011;54(1):21–33.
 10. Castelino RL, Hilmer SN, Bajorek BV, Nishtala P, Chen TF. Drug 
Burden Index and potentially inappropriate medications in community-
dwelling older people: the impact of Home Medicines Review. Drugs 
Aging. 2010;27(2):135–148.
 11. Castelino RL, Bajorek BV, Chen TF. Targeting suboptimal  prescribing 
in the elderly: a review of the impact of pharmacy services. Ann 
 Pharmacother. 2009;43(6):1096–1106.
 12. Castelino RL, Bajorek BV, Chen TF. Retrospective evaluation of home 
medicines review by pharmacists in older Australian patients using the 
medication appropriateness index. Ann Pharmacother. 2010;44(12): 
1922–1929.
 13. Micromedex® Healthcare Series. Greenwood Village, CO: Thomson 
Micromedex; 2014.
 14. Australian Commission on Safety and Quality in Health Care, National 
Standard for the Application of Tall Man Lettering. Sydney: WHO Col-
laborating Centre for Patient Safety Solutions, Look-Alike Sound-Alike 
Medication Names; 2007.
 
In
te
rn
at
io
na
l M
ed
ica
l C
as
e 
Re
po
rts
 J
ou
rn
al
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
60
.2
41
.3
8.
16
2 
on
 0
7-
Ap
r-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
